<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2018</study_start_year><data_sharing_plan>IPD Sharing (as of August 2019): No
Description: No sharing</data_sharing_plan><condition>Outcome, Fatal</condition><condition>Colorectal Neoplasms</condition><disease>Outcome, Fatal</disease><disease>Colorectal Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2280194</full_dataset_link><location>South Korea</location><study_start_month>3</study_start_month><keyword>Postoperative complication</keyword><keyword>Sugammadex</keyword><keyword>Colorectal surgery</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery</name><description>This study is retrospective study. The purpose of this study is checking the effect of sugammadex on the outcome after colorectal surgery. The outcome is compared among the 2 groups, sugammadex group and non-sugammadex group. The primary parameters of outcome are length of stay, readmission rate, postoperative complications, time interval for first successful oral intake.</description><dates><creation>2018-03-15</creation></dates><accession>2280194</accession><cross_references><ClinicalTrials___gov>NCT03619759</ClinicalTrials___gov></cross_references></HashMap>